Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation
Theranostics · 10.02.2025 · 15 (7) · 3055-3075
DOI: 10.7150/thno.104858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, erschienen am 10.02.2025. Verfasst von Chenggong Sun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, PR China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Drug Resistance, Neoplasm, Histones, Rad51 Recombinase. Die Arbeit wurde bisher 97-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, PR China.
- Gynecology Oncology Key Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, PR China.
- Division of Gynecology Oncology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, PR China.
- Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, 751 24 Uppsala, Sweden.
Zitieren
APA
Sun, C., Li, X., Teng, Q., Liu, X., Song, L., Schiöth, H. B., Wu, H., Ma, X., Zhang, Z., Qi, C., Zhang, H., Song, K., Zhang, Q., & Kong, B. (2025). Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation. Theranostics, 15(7), 3055-3075. https://doi.org/10.7150/thno.104858
Vancouver
Sun C, Li X, Teng Q, Liu X, Song L, Schiöth HB, et al. Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation. Theranostics. 2025;15(7):3055-3075. doi:10.7150/thno.104858
BibTeX
@article{Sun2025,
author = {Sun, Chenggong and Li, Xiao and Teng, Qiuli and Liu, Xihan and Song, Li and Schiöth, Helgi B and Wu, Huan and Ma, Xinyue and Zhang, Zhaoyang and Qi, Changjian and Zhang, Haocheng and Song, Kun and Zhang, Qing and Kong, Beihua},
title = {Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {7},
pages = {3055--3075},
doi = {10.7150/thno.104858}
}
EUVIMED